Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Other Non-Current Liabilities (2023)

Historic Other Non-Current Liabilities for Immunome (IMNM) over the last 1 years, with Q4 2023 value amounting to $1.3 million.

  • Immunome's Other Non-Current Liabilities changed N/A to $1.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Immunome's Other Non-Current Liabilities is $1.3 million.
  • In the past 5 years, Immunome's Other Non-Current Liabilities registered a high of $1.3 million during Q4 2023, and its lowest value of $122000.0 during Q3 2023.